Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
An Observational Study of Patients With Dermatologic Disease
Official title: An Observational Study of Patients With Dermatologic Disease
Status: Opening soon
Description:
TARGET-DERM+ is an observational research study to conduct a comprehensive review of outcomes for patients with dermatologic disease (DD) and providers who treat these patients. The study includes patients managed for DD of any etiology in usual clinical practice in the United States and addresses important clinical questions regarding the management of DD by collecting and analyzing data from patients at academic medical centers and community medical practices and/or data from providers who treat them.
Who can take part: 2000000 participants planned.
Enrollment status: Opening soon. The study started 01 September 2026 and is expected to finish 03 August 2041.
Contact: Lynda Lee Burch.
Source: ClinicalTrials.gov, NCT07748169 (https://clinicaltrials.gov/study/NCT07748169).
Start date: September 01, 2026
Completion date: August 03, 2041
Organizer: Target PharmaSolutions, Inc.
Contact: Lynda Lee Burch
Tel.: 9842340268
Email: lburch@pedestalhealth.com
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- What tests for vitiligo should be done?
Before starting vitiligo therapy, several tests may be recommended to ensure an accurate diagnosis and appropriate treatment plan: Physical Examination A thorough physical exami...
- Vitiligo trials for kids: basics for the parents
Pediatric vitiligo trials · The basics Two parallel studies are evaluating investigational use of ruxolitinib cream in young children — researchers are still finding out how wel...
- Who is prone to vitiligo?
Vitiligo can affect anyone, regardless of gender, age, or race. Vitiligo prevalence is between 0.76% and 1.11% of the U.S. population, including around 40% of those with the con...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.